BIOCRYST PHARMACEUTICALS, INC. 9,090,910 Shares of Common Stock (par value $0.01 per share) Underwriting AgreementUnderwriting Agreement • August 6th, 2018 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 6th, 2018 Company Industry Jurisdiction